Navigation Links
Vasogen Announces First Quarter 2008 Results
Date:4/3/2008

16,725 16,725

Contributed surplus 22,979 22,744

Deficit (387,103) (381,783)

-----------------------------------------------------------------------

18,271 23,356

Future operations

Commitments and contingencies

Subsequent events

-------------------------------------------------------------------------

$ 22,890 $ 28,050

-------------------------------------------------------------------------

-------------------------------------------------------------------------

VASOGEN INC.

(A DEVELOPMENT STAGE COMPANY)

Interim Consolidated Statements of Operations, Deficit and Comprehensive

Income

(In thousands of Canadian dollars, except per share amounts)

(Unaudited)

-------------------------------------------------------------------------

Period from

December 1,

Three months ended 1987 to

February 29, February 28, February 29,

2008 2007 2008

-------------------------------------------------------------------------

Expenses:

Research and development $ 2,778 $ 3,023 $ 241,695

General and administration 2,681 3,588 119,909

Foreign exchange loss (gain) 203 (134) 11,173

-------------------------------------------------------------------------

Loss before the undernoted (5,662) (6,477) (372,777)

Interest expense on senior

conv
'/>"/>

SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
2. Vasogen Announces Third Quarter 2007 Results
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
6. Vasogen to Conduct Year-end 2007 Conference Call
7. Vasogen Announces 2007 Year-End Results
8. The Lancet Publishes Vasogens ACCLAIM Results
9. Vasogens Research Published in European Journal of Neuroscience
10. Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel
11. Vasogen Provides Update on ACCLAIM II Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Can economic incentives such as gift ... of the public to increase their donations of blood? ... Carey Business School Assistant Professor Mario Macis says ... large body of recent research that supports their argument, ... issue of Science that the World Health Organization and ...
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
(Date:5/23/2013)... 23, 2013 PI’s new LPS-24 ... provide 15 mm travel range with closed-loop sensor ... dimensions make these new positioners the ideal choice ... vacuum rated version is also available. , ... datasheets can be found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 ...
(Date:5/23/2013)... Calif. , May 23, 2013 Virobay, ... treatment for pain has reached an important milestone, as ... of VBY-036 - a selective cathepsin S inhibitor.   ... is a double-blind, randomized, placebo-controlled study designed to evaluate ... of VBY-036 in healthy adults. "The initiation ...
Breaking Biology Technology:Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3
... Flexibility and Transmission and ... Induction Functionality --, Medical Design & Manufacturing East DRC,s Metrigraphics Division ... ... Dynamics Research,Corporation,s Metrigraphics Division (Nasdaq: DRCO ), a world-leading,precision manufacturer specializing ...
... 3 BioStorage Technologies, Inc.,(BST), today announced the ... board consists of four life science industry leaders ... and expertise in their,respective fields of study. The ... for the ongoing development of the company,s,services, as ...
... -- Microscopic robots crafted to maneuver separately without any ... years of continuing research led by a Duke University ... do assembly and control at this fine a resolution ... a Duke professor of computer science and biochemistry. , ...
Cached Biology Technology:DRC's Metrigraphics Announces Family of Micro-Induction Coils for Implanted and Traditional Medical Applications 2DRC's Metrigraphics Announces Family of Micro-Induction Coils for Implanted and Traditional Medical Applications 3DRC's Metrigraphics Announces Family of Micro-Induction Coils for Implanted and Traditional Medical Applications 4BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts 2Microrobots dance on something smaller than a pin's head 2Microrobots dance on something smaller than a pin's head 3
(Date:5/22/2013)... NEW YORK CITY, May 22, 2013 U.S. Forest ... multi-disciplinary team that, with funding from the TKF Foundation, ... spaces help communities and individuals recover from tragedy. , ... is one of six projects selected for grant funding. ... spaces and sacred spaces in recovery and resiliency, the ...
(Date:5/22/2013)... Md. (May 22, 2013)The omega 3 fatty acids in ... cardiovascular diseaseso much so that the American Heart Association ... a week, particularly fatty varieties rich in omega 3s. ... a mystery. In a new study, scientists led by ... on this phenomenon by providing evidence that fish oil ...
(Date:5/22/2013)... important new details on how climate change will affect ... in the Journal of Animal Ecology . This ... and informing policymakers of how species are likely to ... is a growing recognition among biologists that climate change ... that this is going to have very important consequences ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2Fish oil may help the heart beat mental stress 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5
... The industrial and research role of sensors ... However, industry demands are increasingly stringent and sophisticated, ... drive the advances needed to achieve these market ... the next generation of sensors will be smaller, ...
... heavily in algae-based biofuels, researchers from the University of ... there are significant environmental hurdles to overcome before fuel ... solution to some of these challenges. These findings ... the U.S. Department of Energy announced last week that ...
... diet by as little as one-half teaspoon (or three grams) ... deaths each year, according to a new study. Such ... smoking and could save the United States about $24 billion ... from the University of California, San Francisco, Stanford University Medical ...
Cached Biology News:Conference to discuss future of nanotechnology enabled sensors 2UVa engineers find significant environmental impacts with algae-based biofuel 2Even small dietary reductions in salt could mean fewer heart attacks, strokes and deaths 2Even small dietary reductions in salt could mean fewer heart attacks, strokes and deaths 3
Cytosol/Particulate Rapid Separation Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: 4C...
Request Info...
Purified anti-human CD182 (CXCR2)...
Peptide-affinity Purified Polyclonal Antibody to Purinergic Receptor P2Y12...
Biology Products: